Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2018 Oct 15;67(9):1474-1476.
doi: 10.1093/cid/ciy350.

Role of Egg-adaptation Mutations in Low Influenza A(H3N2) Vaccine Effectiveness During the 2012-2013 Season

Affiliations
Comment

Role of Egg-adaptation Mutations in Low Influenza A(H3N2) Vaccine Effectiveness During the 2012-2013 Season

Danuta M Skowronski et al. Clin Infect Dis. .
No abstract available

PubMed Disclaimer

Comment in

  • Response to Skowronski and De Serres.
    Cobey S, Grad YH. Cobey S, et al. Clin Infect Dis. 2018 Oct 15;67(9):1476. doi: 10.1093/cid/ciy352. Clin Infect Dis. 2018. PMID: 29688302 Free PMC article. No abstract available.

Comment on

References

    1. Skowronski DM, Janjua NZ, De Serres G, et al. . Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses. PLoS One 2014; 9:e92153. - PMC - PubMed
    1. Koel BF, Burke DF, Bestebroer TM, et al. . Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution. Science 2013; 342:976–9. - PubMed
    1. Cobey S, Gouma S, Parkhouse K, et al. . Poor immunogenicity, not vaccine strain egg adaptation, may explain the low H3N2 influenza vaccine effectiveness in 2012–13. Clin Infect Dis 2018; 67:327–333. - PMC - PubMed
    1. Zost SJ, Parkhouse K, Gumina ME, et al. . Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains. Proc Natl Acad Sci U S A 2017; 114:12578–83. - PMC - PubMed
    1. Skowronski DM, Chambers C, Sabaiduc S, et al. . Interim estimates of 2016/17 vaccine effectiveness against influenza A(H3N2), Canada, January 2017. Euro Surveill 2017; 22:pii=30460 doi:10.2807/1560-7917.ES.2017.22.6.30460 - PMC - PubMed

Substances